Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Chemistry ; 22(11): 3612-20, 2016 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-26563829

RESUMO

The field of imaging has developed considerably over the past decade and recent advances in the area of nanotechnology, in particular nanomaterials, have opened new opportunities. Polymeric nanoparticles are particularly interesting and a number of novel materials, characterized by stimuli-responsive characteristics and fluorescent tagging, have allowed visualization, intracellular labeling and real-time tracking. In some of the latest applications the nanoparticles have been used for imagining of tumor cells, both in vivo and ex vivo.


Assuntos
Nanopartículas/química , Polímeros/química , Diagnóstico por Imagem , Humanos , Nanotecnologia
2.
Eur J Pharm Biopharm ; 85(3 Pt B): 1219-31, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23541514

RESUMO

The effect of plasticizer's (PEG) molecular weight (MW) on PVP based solid dispersions (SDs), prepared by melt mixing, was evaluated in the present study using Tibolone as a poorly water soluble model drug. PEGs with MW of 400, 600, and 2000 g/mol were tested, and the effect of drug content, time and temperature of melt mixing on the physical state of Tibolone, and the dissolution characteristics from SDs was investigated. PVP blends with PEG400 and PEG600 were completely miscible, while blends were heterogeneous. Furthermore, a single Tg recorded in all samples, indicating that Tibolone was dispersed in a molecular lever (or in the form of nanodispersions), varied with varying PEG's molecular weight, melt mixing temperature, and drug content, while FTIR analysis indicated significant interactions between Tibolone and PVP/PEG matrices. All prepared solid dispersion showed long-term physical stability (18 months in room temperature). The extent of interaction between mixture components was verified using Fox and Gordon-Taylor equations. Artificial neural networks, used to correlate the studied factors with selected dissolution characteristics, showed good prediction ability.


Assuntos
Portadores de Fármacos , Norpregnenos/química , Polietilenoglicóis/química , Povidona/química , Tecnologia Farmacêutica/métodos , Química Farmacêutica/métodos , Microscopia , Microscopia Eletrônica de Varredura , Modelos Estatísticos , Redes Neurais de Computação , Polímeros/química , Análise de Regressão , Espectroscopia de Infravermelho com Transformada de Fourier , Temperatura , Difração de Raios X
3.
Int J Pharm ; 448(1): 221-30, 2013 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-23524084

RESUMO

Theranostic polymeric nanocarriers loaded with anticancer drug Taxol and superparamagnetic iron oxide nanocrystals have been developed for possible magnetic resonance imaging (MRI) use and cancer therapy. Multifunctional nanocarriers with a core-shell structure have been prepared by coating superparamagnetic Fe3O4 nanoparticles with block copolymer of poly(ethylene glycol)-b-poly(propylene succinate) with variable molecular weights of the hydrophobic block poly(prolylene succinate). The multifunctional polymer nano-vehicles were prepared using a nanoprecipitation method. Scanning transmission electron microscopy revealed the encapsulation of magnetic nanoparticles inside the polymeric matrix. Energy dispersive X-ray spectroscopy and electron energy loss spectroscopy mapping allowed us to determine the presence of the different material ingredients in a quantitative way. The diameter of the nanoparticles is below 250 nm yielding satisfactory encapsulation efficiency. The nanoparticles exhibit a biphasic drug release pattern in vitro over 15 days depending on the molecular weight of the hydrophobic part of the polymer matrix. These new systems where anti-cancer therapeutics like Taxol and iron oxide nanoparticles (IOs) are co-encapsulated into new facile polymeric nanoparticles, could be addressed as potential multifunctional vehicles for simultaneous drug delivery and targeting imaging as well as real time monitoring of therapeutic effects.


Assuntos
Antineoplásicos Fitogênicos/química , Nanopartículas de Magnetita/química , Paclitaxel/química , Poliésteres/química , Polietilenoglicóis/química , Composição de Medicamentos , Nanopartículas de Magnetita/ultraestrutura , Microscopia Eletrônica de Varredura , Microscopia Eletrônica de Transmissão
4.
Mol Pharm ; 9(10): 2856-62, 2012 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-22845012

RESUMO

This work reports details pertaining to the formation of chitosan nanoparticles that we prepare by the ionic gelation method. The molecular interactions of the ionic cross-linking of chitosan with tripolyphosphate have been investigated and elucidated by means of all-electron density functional theory. Solvent effects have been taken into account using implicit models. We have identified primary-interaction ionic cross-linking configurations that we define as H-link, T-link, and M-link, and we have quantified the corresponding interaction energies. H-links, which display high interaction energies and are also spatially broadly accessible, are the most probable cross-linking configurations. At close range, proton transfer has been identified, with maximum interaction energies ranging from 12.3 up to 68.3 kcal/mol depending on the protonation of the tripolyphosphate polyanion and the relative coordination of chitosan with tripolyphosphate. On the basis of our results for the linking types (interaction energies and torsion bias), we propose a simple mechanism for their impact on the chitosan/TPP nanoparticle formation process. We introduce the ß ratio, which is derived from the commonly used α ratio but is more fundamental since it additionally takes into account structural details of the oligomers.


Assuntos
Quitosana/química , Reagentes de Ligações Cruzadas/química , Géis/química , Modelos Químicos , Nanopartículas/química , Polifosfatos/química , Concentração de Íons de Hidrogênio , Íons/química , Modelos Moleculares , Tamanho da Partícula
5.
Eur J Pharm Biopharm ; 82(1): 175-86, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22732266

RESUMO

In the present study, the efficiency of PVP/PEG200 mixtures as appropriate carries for the preparation of solid dispersions by melt mixing was evaluated. Felodipine (FELO) was used as a poorly water soluble model drug. The effect of several melt mixing parameters, (PVP/PEG ratio, time and temperature of melt mixing, and drug content), on the physical state of FELO and the dissolution characteristics of the dispersions were investigated. DSC, XRD, and SEM analysis revealed that in all cases, amorphous drug nanodispersions were prepared. This was attributed to the increased miscibility of the PVP-FELO system, induced by the presence of PEG200, which acted as plasticizer. FT-IR analysis showed hydrogen bonding between FELO (NH) and the PVP carrier (CO). The release rate of the drug depends mainly on the drug content and is higher in solid dispersions with low drug content and ratio of carrier to plasticizer (PVP/PEG200). The melt mixing variations (time and temperature of mixing) had lower impact on FELO release rate. Finally, artificial neural networks, used to correlate the examined formulation and process variables of hot melt mixing with dissolution parameters, showed good prediction ability.


Assuntos
Felodipino/administração & dosagem , Redes Neurais de Computação , Polietilenoglicóis/química , Povidona/química , Varredura Diferencial de Calorimetria , Portadores de Fármacos/química , Composição de Medicamentos/métodos , Felodipino/química , Ligação de Hidrogênio , Microscopia Eletrônica de Varredura , Nanopartículas , Plastificantes/química , Solubilidade , Espectroscopia de Infravermelho com Transformada de Fourier , Temperatura , Fatores de Tempo , Difração de Raios X
6.
Int J Pharm ; 430(1-2): 318-27, 2012 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-22521711

RESUMO

In the present study chitosan grafted copolymers with poly(ethylene glycol) (CS-g-PEG) were prepared and studied using PEG with molecular weights 2000 and 5000g/mol. The materials were characterized using (1)H NMR, FTIR and WAXD techniques. These polyelectrolytes were ionically crosslinked with tripolyphosphate (TPP) and poly(glutamic acid) (PGA) at different polymer/crosslinking agent ratios (1:1, 2:1, 3:1 and 4:1, w/w) for the nanoencapsulation of bovine serum albumin (BSA). Prepared nanoparticles are spherical in shape with a mean diameter ranging from 150 to 600 nm. The size depends mainly to the molecular weight of the PEG and the crosslinking agent used. The PEG molecular weight also seems to affect the release rate of BSA especially the first burst effect which appears to be high in copolymers containing PEG5000, compared with copolymer prepared with PEG2000, and it is also higher when PGA was used as crosslinking agent, instead of TPP.


Assuntos
Quitosana/análogos & derivados , Reagentes de Ligações Cruzadas/química , Portadores de Fármacos , Nanopartículas , Polietilenoglicóis/química , Ácido Poliglutâmico/química , Polifosfatos/química , Soroalbumina Bovina/química , Química Farmacêutica , Quitosana/química , Composição de Medicamentos , Cinética , Espectroscopia de Ressonância Magnética , Peso Molecular , Nanotecnologia , Tamanho da Partícula , Soroalbumina Bovina/administração & dosagem , Solubilidade , Espectroscopia de Infravermelho com Transformada de Fourier , Tecnologia Farmacêutica/métodos , Difração de Raios X
7.
AAPS PharmSciTech ; 10(1): 138-46, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19191030

RESUMO

Poly(propylene succinate) (PPSu) polymers of average molecular weights from 2,800 to 13,100 g/mol were synthesized and characterized with regard to crystallinity, thermal properties, and cytocompatibility. Higher molecular weight samples exhibited lower degree of crystallinity and melted at lower temperatures. Melting of the polymer appeared to begin at 38 degrees C. PPSu cytocompatibility was investigated based on human umbilical vein endothelial cells viability in the presence of increasing concentrations of polymer, and it was found that PPSu exhibited comparable cytocompatibility with poly(DL-lactide). The feasibility of applying PPSu as a drug carrier was shown for the first time, as solid dispersions and nanoparticles of sodium fluvastatin based in PPSu were prepared. Drug release rates decreased with increasing the molecular weight of PPSu in both solid dispersions and nanoparticles. For dispersions prepared from PPSu of the same molecular weight, drug release rates increased with drug loading. It appears that PPSu applicability as a drug carrier warrants further consideration.


Assuntos
Portadores de Fármacos , Ácidos Graxos Monoinsaturados/química , Inibidores de Hidroximetilglutaril-CoA Redutases/química , Indóis/química , Nanopartículas , Poliésteres/química , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Química Farmacêutica , Cristalização , Composição de Medicamentos , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/patologia , Estudos de Viabilidade , Fluvastatina , Humanos , Cinética , Peso Molecular , Poliésteres/toxicidade , Solubilidade , Tecnologia Farmacêutica/métodos , Temperatura de Transição
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA